Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States

Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma

(2013) M. Bhat et al.   Current Oncology

How to decide about liver transplantation in patients with hepatocellular carcinoma: Size and number of lesions or response to TACE?

(2013) Gerd Otto et al.   JOURNAL OF HEPATOLOGY

Evolving Frequency and Outcomes of Liver Transplantation Based on Etiology of Liver Disease

(2013) Ashwani K. Singal et al.   TRANSPLANTATION

Scientific Registry of Transplant Recipients: Collecting, analyzing, and reporting data on transplantation in the United States

(2013) Susan Leppke et al.   Transplantation Reviews

MELD Exceptions and Rates of Waiting List Outcomes

(2011) A. B. Massie et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System

(2010) K. Washburn et al.   AMERICAN JOURNAL OF TRANSPLANTATION